miR-221 demonstrated oncogenic potential in melanoma and, as shown here in colorectal cancer cells, targeted the tumor repressor AP2a, which regulates Egfl7 and miR-126 expression in colon epithelial cells (Fig. 6I). This evidence concerns the gene EGFL7 and melanoma.